OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

MEDIGENE AG NA O.N./  DE000A1X3W00  /

Frankfurt
5/8/2024  4:50:06 PM Chg. +0.0550 Volume Bid9:58:00 PM Ask9:55:22 PM Market Capitalization Dividend Y. P/E Ratio
1.5200EUR +3.75% 1,500
Turnover: 2,280		 -Bid Size: - -Ask Size: - 37.21 mill.EUR 0.00% -
GlobeNewswire 5/7 Medigene to Present at Upcoming Conferences
GlobeNewswire 5/6 The Benchmark Company Announces Upcoming Healthcare House Call VIRTUAL One-on-One Investor Conferenc...
GlobeNewswire 5/2 Medigene AG Expands Patent Portfolio with European Patent Grant for its NY-ESO-1 – targeted T Cell R...
GlobeNewswire 5/2 Medigene Presents Superior TCR-T Cell Functionality by Inclusion of a Costimulatory Switch Protein
GlobeNewswire 4/26 Medigene AG reports Financial Results and Business Update for Q1 2024
GlobeNewswire 4/25 Medigene presents streamlined 6-day, high stemness TCR-T therapy production process
GlobeNewswire 4/17 Medigene to Present at Upcoming Scientific Conferences
GlobeNewswire 4/8 Medigene Presents Favorable Safety Profile of TCR-T Cells with Costimulatory Switch Protein at AACR ...
GlobeNewswire 4/4 Medigene AG Secures European Patent for its iM-TCR Technology
GlobeNewswire 3/28 Medigene AG Reports Full-Year 2023 Financial Results and Provides Corporate Update
GlobeNewswire 3/19 Medigene AG to participate in the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
GlobeNewswire 3/18 Medigene AG to report full year 2023 financial results on March 28, 2024
GlobeNewswire 3/6 Medigene to Present Favorable Safety Profile of TCR-T Cells upon Addition of Costimulatory Switch Pr...
GlobeNewswire 3/4 Medigene AG Expands Patent Portfolio in Japan for iM-TCR Technology to Directly Control TCR-T Safety...
GlobeNewswire 2/29 Medigene Presents at CAR-TCR Summit Europe Showcasing Unique Approach for Development of Differentia...
GlobeNewswire 2/19 Medigene to Present at Upcoming Conferences
GlobeNewswire 2/12 Medigene Announces Indication Selection for the Clinical Development of its Lead 3rd Generation TCR...
GlobeNewswire 12/19/2023 Medigene AG to attend at the 42nd Annual J.P. Morgan Healthcare Conference
GlobeNewswire 11/21/2023 Medigene AG Announces Prioritization of Pipeline and Resource Allocation as well as Extension of Cas...
GlobeNewswire 11/21/2023 Medigene amends 2023 financial guidance
GlobeNewswire 11/4/2023 Medigene presents new data for MDG2011, the first TCR in a novel KRAS library, demonstrating capabil...
GlobeNewswire 10/26/2023 Medigene Reports Financial Results and Corporate Update for Q3 2023
GlobeNewswire 10/23/2023 Medigene presents first pre-clinical data of optimal affinity TCR targeting mKRAS G12V combined with...
GlobeNewswire 10/16/2023 Medigene to present new pre-clinical data for pipeline TCR-T therapies at the ESMO Congress 2023
GlobeNewswire 9/27/2023 Medigene AG Secures European Patent for its PD1-41BB Costimulatory Switch Protein